[
  {
    "trial_id": "NCT03301350",
    "mcode_elements": {
      "extracted_entities": [],
      "mcode_mappings": [
        {
          "element_type": "CancerCondition",
          "code": "254837009",
          "display": "Malignant neoplasm of breast",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "Conditions: Breast Cancer"
        },
        {
          "element_type": "CancerCondition",
          "code": "722713003",
          "display": "Triple negative breast cancer",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "Triple Negative Breast Cancer"
        },
        {
          "element_type": "CancerCondition",
          "code": "254837009",
          "display": "Triple negative breast cancer",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "subjects with triple-negative breast cancer"
        },
        {
          "element_type": "CancerTreatment",
          "code": "387136007",
          "display": "Carboplatin",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "low dose weekly Carboplatin/Paclitaxel"
        },
        {
          "element_type": "CancerTreatment",
          "code": "387168002",
          "display": "Paclitaxel",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "low dose weekly Carboplatin/Paclitaxel"
        },
        {
          "element_type": "CancerTreatment",
          "code": "387120007",
          "display": "Doxorubicin",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "dose-dense Doxorubicin/Cyclophosphamide"
        },
        {
          "element_type": "CancerTreatment",
          "code": "387131008",
          "display": "Cyclophosphamide",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "dose-dense Doxorubicin/Cyclophosphamide"
        },
        {
          "element_type": "CancerTreatmentIntent",
          "code": "373808002",
          "display": "Neoadjuvant therapy",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "in neoadjuvant settings"
        },
        {
          "element_type": "CancerCondition",
          "code": "254837009",
          "display": "Malignant neoplasm of breast",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer"
        },
        {
          "element_type": "CancerTreatment",
          "code": "387544002",
          "display": "Carboplatin",
          "system": "http://snomed.info/sct",
          "confidence_score": 0.9,
          "evidence_text": "Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer"
        },
        {
          "element_type": "CancerTreatment",
          "code": "387168001",
          "display": "Paclitaxel",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer"
        },
        {
          "element_type": "CancerTreatment",
          "code": "387120007",
          "display": "Doxorubicin",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer"
        },
        {
          "element_type": "CancerTreatment",
          "code": "387499004",
          "display": "Cyclophosphamide",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer"
        },
        {
          "element_type": "CancerTreatment",
          "code": "424877005",
          "display": "Neoadjuvant therapy",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer"
        }
      ],
      "source_references": [],
      "validation_results": "compliance_score=1.0 validation_errors=[] validation_warnings=[] required_elements_present=[] missing_elements=[]",
      "metadata": "engine_type='LLM' entities_count=0 mapped_count=14 processing_time_seconds=None model_used=None prompt_used=None token_usage=TokenUsage(prompt_tokens=800, completion_tokens=892, total_tokens=1692)",
      "token_usage": "prompt_tokens=800 completion_tokens=892 total_tokens=1692",
      "error": null,
      "natural_language_summary": "NCT03301350 is a clinical trial (mCODE: Trial) entitled 'Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer'. Trial study type (mCODE: TrialStudyType) is interventional study. Trial status (mCODE: TrialStatus) is completed. Trial cancer conditions (mCODE: TrialCancerConditions) include Breast Cancer. Trial age criteria (mCODE: TrialAgeCriteria) requiring patients of any gender (mCODE: TrialSexCriteria). Trial sex criteria (mCODE: TrialSexCriteria) requiring patients and does not accept healthy volunteers (mCODE: TrialHealthyVolunteers). Trial healthy volunteers criteria (mCODE: TrialHealthyVolunteers) is . Trial start date (mCODE: TrialStartDate) is 2017-11-07. Trial completion date (mCODE: TrialCompletionDate) is 2022-02-07."
    }
  },
  {
    "trial_id": "NCT01367418",
    "mcode_elements": {
      "extracted_entities": [],
      "mcode_mappings": [
        {
          "element_type": "CancerCondition",
          "code": "399068003",
          "display": "Malignant neoplasm of prostate",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "Conditions: Prostate Cancer"
        },
        {
          "element_type": "CancerCondition",
          "code": "363346000",
          "display": "Malignant neoplastic disease",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "\"colorectal, breast and prostate cancers and malignant melanoma\""
        },
        {
          "element_type": "CancerTreatment",
          "code": "385871007",
          "display": "Regional anesthesia",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "\"regional anaesthesia (RA)\""
        },
        {
          "element_type": "CancerTreatment",
          "code": "385871007",
          "display": "Regional anesthesia",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "\"Thoracic epidural analgesia (TEA)\""
        },
        {
          "element_type": "CancerTreatment",
          "code": "385871007",
          "display": "Regional anesthesia",
          "system": "http://snomed.info/sct",
          "confidence_score": 1.0,
          "evidence_text": "\"patient controlled analgesia (PCA)\""
        },
        {
          "element_type": "CancerCondition",
          "code": "399068003",
          "display": "Malignant neoplasm of prostate",
          "system": "http://snomed.info/sct",
          "confidence_score": 0.9,
          "evidence_text": "Following Radical Prostatectomy"
        }
      ],
      "source_references": [],
      "validation_results": "compliance_score=1.0 validation_errors=[] validation_warnings=[] required_elements_present=[] missing_elements=[]",
      "metadata": "engine_type='LLM' entities_count=0 mapped_count=6 processing_time_seconds=None model_used=None prompt_used=None token_usage=TokenUsage(prompt_tokens=790, completion_tokens=173, total_tokens=963)",
      "token_usage": "prompt_tokens=790 completion_tokens=173 total_tokens=963",
      "error": null,
      "natural_language_summary": "NCT01367418 is a clinical trial (mCODE: Trial) entitled 'Effects of Anesthetic Technique on Immune and Inflammatory Systems Following Radical Prostatectomy'. Trial study type (mCODE: TrialStudyType) is interventional study. Trial status (mCODE: TrialStatus) is completed. Trial cancer conditions (mCODE: TrialCancerConditions) include Prostate Cancer. Trial age criteria (mCODE: TrialAgeCriteria) requiring patients of any gender (mCODE: TrialSexCriteria). Trial sex criteria (mCODE: TrialSexCriteria) requiring patients and does not accept healthy volunteers (mCODE: TrialHealthyVolunteers). Trial healthy volunteers criteria (mCODE: TrialHealthyVolunteers) is . Trial start date (mCODE: TrialStartDate) is 2010-09. Trial completion date (mCODE: TrialCompletionDate) is 2012-03."
    }
  }
]